Ignite Creation Date:
2024-05-05 @ 11:27 AM
Last Modification Date:
2024-10-26 @ 9:07 AM
Study NCT ID:
NCT00044291
Status:
COMPLETED
Last Update Posted:
2015-07-31
First Post:
2002-08-23
Brief Title:
Phase III Study of Atamestane Plus Toremifene Versus Letrozole in Advanced Breast Cancer
Sponsor:
Intarcia Therapeutics
Organization:
Intarcia Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Neoplasms Hormone-dependent |
| Breast Neoplasms |
Keywords:
| Name | View |
|---|---|
| recurrent breast cancer | View |
| Atamestane | View |
| Toremifene | View |
| Letrozole | View |
| Aromatase inhibitor | View |
| Receptor-positive | View |
| First line therapy | View |
| Estrogen blocker | View |
| Metastatic breast cancer | View |
| Locally advanced breast cancer | View |
| Locally recurrent breast cancer | View |
| stage IV breast cancer | View |
| ductal breast carcinoma | View |
| lobular breast carcinoma | View |
| stage IIIA breast cancer | View |
| stage IIIB breast cancer | View |